v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 1,577 $ 1,404
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion (including amortization of nuclear fuel) 1,884 1,691
Equity component of AFUDC (88) (70)
Gain on sale of Piedmont's Tennessee business (368)  
Gains on sales of other assets (16) (6)
Deferred income taxes 412 192
Equity in (earnings) losses of unconsolidated affiliates (7) (11)
Payments for asset retirement obligations (119) (102)
(Increase) decrease in    
Net realized and unrealized mark-to-market and hedging transactions 0 85
Receivables 336 150
Inventory 1 99
Other current assets (328) 107
Increase (decrease) in    
Accounts payable (302) (866)
Taxes accrued (139) (52)
Other current liabilities (460) (468)
Other assets (936) (60)
Other liabilities 65 84
Net cash provided by operating activities 1,512 2,177
CASH FLOWS FROM INVESTING ACTIVITIES    
Capital expenditures (4,088) (3,148)
Purchases of debt and equity securities (5,025) (1,966)
Proceeds from sales and maturities of debt and equity securities 5,037 2,051
Proceeds from the sale of Piedmont's Tennessee business 2,501 0
Other (271) (237)
Net cash used in investing activities (1,846) (3,300)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of long-term debt 3,268 4,096
Issuance of common stock   7
Payments for the redemption of long-term debt (2,577) (996)
Proceeds from the issuance of short-term debt with original maturities greater than 90 days 262  
Payments for the redemption of short-term debt with original maturities greater than 90 days (125) (5)
Notes payable and commercial paper (428) (1,050)
Contributions from noncontrolling interests 2,778  
Dividends paid (846) (803)
Other (109) (11)
Net cash provided by financing activities 2,223 1,238
Net increase (decrease) in cash, cash equivalents and restricted cash 1,889 115
Cash, cash equivalents and restricted cash at beginning of period 363 421
Cash, cash equivalents and restricted cash at end of period 2,252 536
Significant non-cash transactions:    
Accrued capital expenditures $ 2,313 $ 1,900